Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid Tumors

Clinical trial NCT01337505 · COMPLETED

Trial details

NCT number: NCT01337505
Sponsor: ImmunityBio, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumour

Start date: 2011-04-01
Primary completion: 2012-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.